These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 8912857

  • 1. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE, Chan DC, Chou TC, Kumar R, Bunn PA.
    Cancer Res; 1996 Nov 15; 56(22):5198-204. PubMed ID: 8912857
    [Abstract] [Full Text] [Related]

  • 2. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
    Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R.
    Cancer; 1996 May 01; 77(9):1940-6. PubMed ID: 8646696
    [Abstract] [Full Text] [Related]

  • 3. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
    Steinberg L, Hassan M, Olmsted L, Sharan V, Stepnick D, Hoppel C, Mugharbil A, Subramanyan S, McGloin B, Mackay W, Strauss M.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
    Hoffmann W, Rodemann HP, Belka C, Budach W, Schmidberger H, Bochtler H, Heinrich V, Bamberg M.
    Semin Oncol; 1997 Feb 01; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
    [Abstract] [Full Text] [Related]

  • 5. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
    Dowell JE, Sinard R, Yardley DA, Aviles V, Machtay M, Weber RS, Weinstein GS, Chalian AA, Carbone DP, Rosenthal DI.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):97-101. PubMed ID: 10210547
    [Abstract] [Full Text] [Related]

  • 6. Taxol plus radiation for head and neck cancer.
    Rosenthal DI, Carbone DP.
    J Infus Chemother; 1995 Apr 01; 5(2):46-54. PubMed ID: 8521234
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr 01; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 8. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
    Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF, Mohiuddin M, Ahmed MM.
    Clin Cancer Res; 2003 Apr 01; 9(4):1557-65. PubMed ID: 12684432
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
    Niero A, Emiliani E, Monti G, Pironi F, Turci L, Valenti AM, Marangolo M.
    Clin Cancer Res; 1999 Aug 01; 5(8):2213-22. PubMed ID: 10473108
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 11. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies.
    Rosenthal DI, Okani O, Truelson JM, Fathallah-Shaykh H, Vuitch FM, Gazdar AF, Griener J, Landay M, Mendelsohn D, Tourville J, Hamilton L, Orr KY, McWhorter J, Carbone DP.
    Semin Oncol; 1997 Feb 01; 24(1 Suppl 2):S2-81-S2-84. PubMed ID: 9045344
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 16. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Van Waes C.
    Clin Cancer Res; 2004 Dec 15; 10(24):8665-73. PubMed ID: 15623651
    [Abstract] [Full Text] [Related]

  • 17. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 15; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 18. Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
    Flood W, Lee DJ, Trotti A, Spencer S, Murphy B, Khuri F, DeConti R, Wheeler R, Forastiere AA.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):64-9. PubMed ID: 10210542
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
    Vokes EE, Haraf DJ, Brockstein BE, Weichselbaum RR.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):70-6. PubMed ID: 10210543
    [Abstract] [Full Text] [Related]

  • 20. Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study.
    Rosenthal DI, Sinard RJ, Okani O, Corak J, Kavanaugh D, Kamen B, Vuitch FM, Gazdar AF, Griener J, Frenkel EP, Carbone DP.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-67-S19-71. PubMed ID: 9427270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.